“Physicians are under pressure to defend their clinical decision-making and prescribing practices through a more stringent lens, while pharmaceutical companies are expected to provide more evidence to demonstrate the overall value (and justify the cost) of their specialty medications.” Read the full article and e-book at: knowledgedriven.com
It’s no secret that there is a lot of noise in the marketplace. How can you make sure your ideas are heard? One way is to communicate with multiple members of the oncology care team, not just with physicians. Care team members include nurses, advanced practice providers (NPs and PAs), payers, and office staff. That way, you can share new information and evidence about treatments and reach the team members whose decisions impact patient care. Any of these individuals can start the conversation as long as you connect the importance of your message to patient impact.
Communicating with key members of the oncology team and with payers means that patients benefit.